Finally, Timothy Caulfield and colleagues discuss the growing transnational travel of patients looking for highly experimental stem cell “treatments” at very high financial costs — stem cell tourism. They raise doubt about the effectiveness of legal prohibitions. Such prohibitions, they suggest, are unlikely to deter this lucrative industry which preys on highly motivated but often ill-informed patients. Rather than focus on complex international regulations, they suggest the path forward requires improved patient education, which should inform decision-making and may deter stem cell tourism. Because prospective patients of these therapies tend to doubt the reasonableness of decisions made in the context of their own health care system and the approval process for new therapies, education should focus on the nature and importance of translational research and regulation and the ultimate goals of assessing both efficacy and safety. Educational material, they argue, needs to be readily available online in order to be effective.